N. Zealand Group Presses Pharmac To Cover Servier’s Heart Drug
This article was originally published in PharmAsia News
Executive Summary
New Zealand’s Heart Foundation is pressing Pharmac to cover Les Laboratoires Servier’s potassium channel blocke Procoralan (ivabradine) for reducing heart rates.